Abstract Medicinal plants play a significant role in traditional and modern medicine. Ginkgo biloba (G. biloba), an ancient plant used in traditional Chinese medicine for over 5000 years, has diverse pharmacological actions, including neuroprotective, anti-inflammatory, and cardioprotective effects. Despite its extensive usage, systematic homoeopathic trials to understand its pathogenetic effects are limited. To elicit the pathogenetic effects of G. biloba on healthy human volunteers. A multicenter, double-blind, randomized, placebo-controlled homoeopathic pathogenetic trial was conducted across three centers in India to assess the effects of G. biloba on apparently healthy volunteers and identify its symptomatology. This study included 48 healthy volunteers (15 males and 33 females), randomized into a verum group (n = 31) and a control group (n = 17). The trial was conducted using four potencies of G. biloba (6C, 12C, 30C, and 200C) administered in a controlled, blinded manner. Data was recorded using a standardized format. Qualitative and quantitative analyses were performed, comparing baseline and post-trial observations, including laboratory and radiological findings. The verum group (31 provers) had a pathogenetic incidence rate of 32.25%, with an average of two symptoms per prover. The drug has shown its effects on almost all the organ systems, including the mind. Symptoms included anxiety, restlessness, headache, and skin complaints which were already present in old literature and a few new symptoms were reported. The overall pathogenetic effects seem to be deficient in contrast to its extensive use in scientific literature. Future studies using lower, non-toxic potencies may be conducted in diverse geographic regions to explore additional therapeutic applications and enhance the clinical relevance of G. biloba.
Abstract Clinical documentation is a foundational yet inconsistently practiced element of homeopathy, despite its central role in clinical reasoning, education, research, ethics, and professional accountability. Historically, homeopathy has relied on detailed case records to develop its Materia Medica and therapeutic principles; however, contemporary practice shows wide variation in the depth, structure, and consistency of documentation. This article examines whether systematic clinical documentation is necessary in homeopathy and, if yes, its purpose and minimum standard. Drawing on historical evolution, current reporting frameworks, and evidence from routine clinical practice, the article highlights how well-maintained case records support accurate case analysis, longitudinal follow-up, pharmacovigilance, medico-legal safety, and the generation of analyzable data for research. Particular emphasis is placed on the transition from routine clinical notes to publishable case records, underscoring the importance of case summaries, sequential documentation of objective evidence (including investigations, imaging, and photographic records), and incorporation of patient perspectives. The relevance of established reporting frameworks such as CARE (CAse REports), the homeopathy-specific HOM-CASE (Homeopathic Clinical Case) extension, and the PITCH (Preferred Items for Reporting Case series in Homeopathy) guideline for case series are discussed as a means to enhance transparency, reproducibility, and scientific credibility. The article also outlines practical barriers to documentation and proposes pragmatic strategies involving structured templates, education, digitization, and supportive regulation. It argues that systematic clinical documentation and responsible publication of case records are not administrative burdens or external impositions but an evolution of homeopathy's own epistemological tradition, essential for improving clinical quality, strengthening the evidence base, and enhancing credibility within pluralistic health care systems.
Abstract Xenoglossophobia, or intense anxiety when faced with foreign languages, is associated with psychological distress, cognitive blocking, and academic and professional impairment. There are no standardized therapeutic protocols for this condition in conventional medicine. This article aims to discuss xenoglossophobia as a context-specific manifestation conceptually aligned with performance anxiety and social phobia, and to explore, in a hypothesis-generating manner, the potential role of homeopathy based on the existing literature on anxiety, phobias, and performance fear. Narrative review of the literature in biomedical databases and homeopathy journals, including clinical trials, systematic reviews, observational studies, and case reports addressing anxiety disorders, performance anxiety, and phobias is presented here. No studies specifically evaluating homeopathic treatment for xenoglossophobia were identified. Xenoglossophobia shares several psychological and neurobiological features with social anxiety and performance anxiety, including fear of negative evaluation, autonomic hyperreactivity, and cognitive interference under stress. Studies on homeopathy in anxiety disorders and phobias show heterogeneous and limited evidence, with both positive and negative findings. Homeopathic medicines such as Gelsemium sempervirens, Argentum nitricum, Lycopodium clavatum, and others are commonly used in clinical practice for anticipatory and performance-related anxiety, although direct evidence for xenoglossophobia is lacking. While no clinical studies have directly evaluated homeopathy in xenoglossophobia, the conceptual overlap with performance anxiety and social phobia allows the formulation of testable hypotheses for future research. This narrative review aims to open a new field of clinical and scientific inquiry rather than to support definitive therapeutic recommendations.
Abstract Personality disorders are characterized by a pervasive pattern of thought, feeling, and behavior that define an individual's unique lifestyle and mode of adaptation, which deviates markedly from the expectations of the individual's culture. The integrative review method combines diverse research methodologies to evaluate evidence, identify gaps, and propose future research. This review proposes exploring homeopathic approaches, emphasizing the need for more research in this area and detailing the objectives of the study to identify effective homeopathic treatments for different personality disorders using the International Classification of Diseases 10th Revision (ICD-10) criteria. A thorough literature review was conducted across various databases, including PubMed, Medscape, Google Scholar, and others, up to 2023. Keywords related to personality, personality disorders, and homoeopathy were employed. Six relevant studies were identified and screened based on predefined criteria, and the diagnostic criteria for each personality disorder were transformed into rubrics using Synthesis 10.0 in RadarOpus software. In the context of homeopathy and personality disorders, six evaluated studies suggested the effectiveness of homeopathic treatments. After transferring the symptoms of personality disorders (F60) in ICD-10 into rubrics, frequently indicated medicines include Lachesis, Lycopodium, Pulsatilla, Arsenicum album, Sulphur, and Phosphorus. The review emphasizes the scarcity of rigorous studies, highlights homeopathy's potential for treating personality disorders and proposes randomized controlled trials for a more robust evidence base.
Abstract Intellectual disability, previously known as mental retardation, can be caused by a combination of environmental and genetic factors, leading to cognitive and social impairments. According to the American Association on Intellectual and Developmental Disability, it is a disability that manifests before the age of 18 and is characterized by substantial limitations in both intellectual functioning such as reasoning, learning, and problem-solving and adaptive behavior including conceptual, social, and practical skills. Homoeopathic medicines can be effective in intellectual disability by managing behavior and related conditions, but evidence is still limited. This article critically evaluates, summarizes, and synthesizes published research findings, and assesses the reported effectiveness of homeopathic treatment in intellectual disability. We searched across multiple international databases and portals, including PubMed, Medscape, Google Scholar, Wiley Online Library, Springer, Scopus, and the AYUSH portal, to collect relevant publications such as reviews, research articles, case series, and case reports up to the year 2024. Various search terms were utilized to ensure an extensive investigation into topics related to intellectual disability, homeopathy, and mental retardation. Due to the limited number of literature available, only 15 studies related to Intellectual disability were found and were evaluated by considering factors such as references, publication year, clinical conditions, sample size, study design, intervention/comparator, outcome, and results in the search results using keywords. Out of these 15 studies, a total of nine studies three case reports, five prospective observational studies, and one pilot study met the inclusion criteria and were carefully reviewed, considering factors such as study design, methodology, the homoeopathic medicine administered, and observed outcomes. the full texts with abstract of these nine studies. Individualized homoeopathic treatment showed promising possible benefit as a complementary approach in managing behavioral and functional challenges in individuals with intellectual disability. Insufficient research on evidence-based parameters necessitates randomized controlled trials with validated scales for intellectual disability disorder.
Abstract Autism spectrum disorder (ASD) is a complex neurodevelopmental condition characterized by deficits in social interaction, communication, and repetitive behaviors. While conventional therapies aim to manage symptoms, individualized homeopathic treatment focuses on the patient's constitutional characteristics and the totality of symptoms. This case report describes the management of a 6-year-old boy diagnosed with ASD who presented with poor eye contact, delayed speech, hypersensitivity to noise, repetitive behaviors, emotional sensitivity, and a chilly constitution with profuse perspiration of palms and soles. Baseline assessment using the Childhood Autism Rating Scale–Second Edition (CARS-2) showed a score of 41.5, indicating severe autism. Based on individualized symptom analysis and repertorial evaluation, Silicea was selected as the constitutional remedy and administered in a single dose of 200C potency. Over a 12-month follow-up period, progressive improvements were observed in sleep, sensory tolerance, speech development, and social interaction. Reassessment using CARS-2 demonstrated a reduction of the score to 25.5, indicating substantial clinical improvement. This case highlights the potential role of individualized homeopathic treatment as a complementary approach in the management of ASD. Although the findings cannot be generalized from a single case, the observed clinical improvement supported by standardized assessment tools suggests that further systematic research in this area may be warranted.
Abstract Generalized anxiety disorder (GAD) is a distressing mental health condition characterized by persistent and excessive worry that surpasses specific triggers. Anxiety disorders can lead to work and school absences and present a larger cost burden than other psychiatric disorders due to their higher prevalence of around 642 million sufferers globally. The usefulness of Homeopathy in GAD has been studied to some extent, but the approach and posology are not discussed. Three individuals who presented with symptoms of free-floating anxiety and autonomic symptoms were diagnosed with GAD based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria. The cases were analyzed systematically and treated with individualized homeopathic medicines in fifty millesimal potencies. Detailed case assessments were conducted using standardized record forms, and symptom analysis followed by repertorization utilizing RADAR Opus software and medicines Magnesium carb, Calcarea mur, and Pulsatilla nigricans were selected based on the repertorial totality and final consultation with materia medica and prescribed in LM (Q) potencies starting with 0/1. Severity at baseline and progress were evaluated monthly using the Hamilton Anxiety Scale (HAM-A). The World Health Organization Quality of Life brief version (WHO QoL BREF) was administered once in 6 months. MONARCH inventory was used for eliciting a causal relationship between the homeopathic intervention and outcome. A significant reduction in HAM-A scores and WHO QoL BREF scores was noted after treatment, indicating the usefulness of individualized homeopathic treatment in GAD. HAM-A scores of 49, 27, and 48 at baseline turned to 0, 5, and 0, respectively, at the end of the 1-year observation period. These findings offer initial evidence supporting the utility of millesimal potencies of individualized homeopathic medicines in managing GAD and highlight the importance of further research in this field.
Abstract Global developmental delay (GDD) is a neurodevelopmental disorder involving significant delays in two or more developmental domains. It often coexists with behavioral disturbances and sensory processing issues, necessitating multidisciplinary care. Evidence for homeopathy in GDD is limited, particularly when sensory processing disorder (SPD) is present. A 4-year-old male child with mild GDD comorbid with SPD, speech delay, hyperactivity, aggression, and compulsive behaviors (urine drinking, spitting, mouthing objects) was treated with individualized homeopathy. Antenatal history revealed significant maternal emotional trauma and depression during pregnancy. Based on the totality of symptoms, including maternal stress, Lycopodium clavatum 200C was prescribed as a single dose, followed by placebo, and repeated once after a febrile exacerbation. Over 12 months, marked improvement was observed in speech (from single words to age-appropriate fluency), comprehension, attention span, toileting habits, and social interaction. Compulsive and aggressive behaviors resolved. The social quotient improved from 54 (mild delay) to 84 (within borderline range), and the developmental quotient from 62 at baseline to 89 after 12 months. Minimal and irregular therapy sessions were received during this period. Causality assessment was done using the Modified Naranjo Criteria for Homeopathy (MONARCH), which yielded a score of +8 out of a maximum possible +13. Although improvement was observed during the course of treatment, a direct causal relationship between the intervention and the observed improvement cannot be definitively established. This case suggests possible benefit of individualized homeopathy in managing GDD with coexisting SPD, highlighting the importance of considering antenatal maternal stress in remedy selection. Further controlled studies are needed to validate these findings.
Abstract Social anxiety disorder (SAD) involves the fear of social situations, including situations that involve scrutiny or contact with strangers. Usually, SAD is associated with low self-esteem and fear of criticism, which can affect the quality of life of patients as they often avoid social situations. A 23-year-old male patient having SAD managed with individualized homeopathic medicine, Acid Phosphoricum in 50 millesimal potency, at the outpatient department of the National Homoeopathy Research Institute in Mental Health (NHRIMH) is presented here. The Liebowitz Social Anxiety Scale (LSAS) was used for the assessment of severity at baseline and at subsequent follow-up visits. Remarkable improvement was observed in the case. The baseline LSAS score of 97 (severe SAD) changed to 22 (normal) after 4 months of intervention and became 7 at the sixth month. Individualized homeopathic medicine in 50 millesimal potencies can be considered in the management of patients with SAD. More valid evidence can be obtained with well-planned research designs.
